Stay updated on Safety of SAGE-718 in Huntington's Disease Clinical Trial
Sign up to get notified when there's something new on the Safety of SAGE-718 in Huntington's Disease Clinical Trial page.

Latest updates to the Safety of SAGE-718 in Huntington's Disease Clinical Trial page
- Check2 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedRevision: v3.4.2 added; the government funding status notice and the prior revision notice (v3.4.1) were removed.SummaryDifference0.3%

- Check37 days agoChange DetectedA site-wide funding status notice was added, stating that the information may not be up to date and directing users to cc.nih.gov and opm.gov, and the page revision tag updated to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check45 days agoChange DetectedGlossary feature added and page footer updates include 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', with the revision now shown as v3.4.0.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing the previous v3.3.3. This appears to be a document version update with no visible changes to the study information.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page now lists 43 study locations across the United States, United Kingdom, Canada, and Australia, expanding from the previous number of sites. It also shows that results were posted on 2025-12-17.SummaryDifference13%

Stay in the know with updates to Safety of SAGE-718 in Huntington's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of SAGE-718 in Huntington's Disease Clinical Trial page.